Furthermore, elevated expression of central and peripheral complement components C3 and C4 has been reported in patients with generalized anxiety disorder, major depressive disorder, and schizophrenia (Shatri et al., 2023; Pillai, 2022; Sekar et al., 2016a). This evidence concerns the gene C3 and schizophrenia.